Skip to main content
VIB.BE
en
  • English
  • Dutch
About
Home
  • Research & Impact
    • Research Areas
      • Immunity & Inflammation
      • Cancer Research
      • Medical Biotechnology
      • Neuroscience
      • Plant Biology
      • Microbiology
      • Structural Biology
      • Computational Biology
    • Research Centers
      • Center for Cancer Biology
      • VIB.AI: Center for AI & Computational Biology
      • Center for Inflammation Research
      • Center for Medical Biotechnology
      • Center for Microbiology
      • Center for Molecular Neurology
      • Center for Structural Biology
      • Center for Plant Systems Biology
      • VIB-KU Leuven Center for Neuroscience
    • Grand Challenges
      • Selected projects
      • Societal impact
      • Upcoming call
      • Modalities
      • Contact
    • Translational Research
    • Research Impact
      • IPBO
      • Biotech for security and public health resilience
      • Aureus Nova Scientia Prize
    • Publications
    • Responsible Research
      • Why animal research is necessary
    • Research Infrastructure
      • ESFRI
  • Business
    • Business Development
      • VIB’s Business Development team
      • Technology transfer
    • New Ventures
      • From idea to spin-off
      • Embarking on a long-term adventure
      • VIB's Spin-offs
    • Intellectual Property
    • Ecosystem
      • Biotope
    • Discovery Sciences
      • Internship program
    • AI Studio
    • Success Stories
      • Towards a COVID-19 Drug
      • Revolutionary diagnostic cancer test
      • On the road to new asthma therapeutics
      • Antibodies for piglets
      • Agribiotech cluster in Ghent
      • Blood test for liver diseases
      • Safe test for mother and child
      • Toward new cancer medicines
      • Experimental micro-brewery of VIB and KU Leuven
      • Nanobodies, our legacy
      • DNA sequencing tools with our technology
    • Facilities
  • Technologies
    • Tech Portfolio
      • Bioimaging
      • Flow cytometry
      • Metabolomics
      • Nanobody production
      • Nucleomics
      • Protein production
      • Proteomics
      • Research data services
      • Screening
      • Single cell technology
      • Technology scouting
      • Spatial Catalyst
    • About VIB technologies
      • Our dual mission
      • Meet our experts
      • Technology Training
      • Jobs
      • Core for Life
      • Partner with VIB Technologies
  • Public Outreach
    • Facts Series
    • Educational Projects
    • Events
  • News
    • Press
    • Called to Science
    • VIBTimes
    • Blog
    • In the spotlight
      • VIB Microbes
      • VIB Lessons from Plants
      • VIB Technologies
      • Neuroscience
  • Training & Conferences
    • Partner events
  • Careers
    • Jobs
    • Why VIB?
    • DE&I
    • Supporting your journey
    • Grants Office
    • Why Flanders?
  • Research & Impact
    • Research Areas
      • Immunity & Inflammation
      • Cancer Research
      • Medical Biotechnology
      • Neuroscience
      • Plant Biology
      • Microbiology
      • Structural Biology
      • Computational Biology
    • Research Centers
      • Center for Cancer Biology
      • VIB.AI: Center for AI & Computational Biology
      • Center for Inflammation Research
      • Center for Medical Biotechnology
      • Center for Microbiology
      • Center for Molecular Neurology
      • Center for Structural Biology
      • Center for Plant Systems Biology
      • VIB-KU Leuven Center for Neuroscience
    • Grand Challenges
      • Selected projects
      • Societal impact
      • Upcoming call
      • Modalities
      • Contact
    • Translational Research
    • Research Impact
      • IPBO
      • Biotech for security and public health resilience
      • Aureus Nova Scientia Prize
    • Publications
    • Responsible Research
      • Why animal research is necessary
    • Research Infrastructure
      • ESFRI
  • Business
    • Business Development
      • VIB’s Business Development team
      • Technology transfer
    • New Ventures
      • From idea to spin-off
      • Embarking on a long-term adventure
      • VIB's Spin-offs
    • Intellectual Property
    • Ecosystem
      • Biotope
    • Discovery Sciences
      • Internship program
    • AI Studio
    • Success Stories
      • Towards a COVID-19 Drug
      • Revolutionary diagnostic cancer test
      • On the road to new asthma therapeutics
      • Antibodies for piglets
      • Agribiotech cluster in Ghent
      • Blood test for liver diseases
      • Safe test for mother and child
      • Toward new cancer medicines
      • Experimental micro-brewery of VIB and KU Leuven
      • Nanobodies, our legacy
      • DNA sequencing tools with our technology
    • Facilities
  • Technologies
    • Tech Portfolio
      • Bioimaging
      • Flow cytometry
      • Metabolomics
      • Nanobody production
      • Nucleomics
      • Protein production
      • Proteomics
      • Research data services
      • Screening
      • Single cell technology
      • Technology scouting
      • Spatial Catalyst
    • About VIB technologies
      • Our dual mission
      • Meet our experts
      • Technology Training
      • Jobs
      • Core for Life
      • Partner with VIB Technologies
  • Public Outreach
    • Facts Series
    • Educational Projects
    • Events
  • News
    • Press
    • Called to Science
    • VIBTimes
    • Blog
    • In the spotlight
      • VIB Microbes
      • VIB Lessons from Plants
      • VIB Technologies
      • Neuroscience
  • Training & Conferences
    • Partner events
  • Careers
    • Jobs
    • Why VIB?
    • DE&I
    • Supporting your journey
    • Grants Office
    • Why Flanders?
  • Log in
en
  • English
  • Dutch
About

Nanobodies, our legacy

In 1989, Professor Raymond Hamers' laboratory at VUB discovered a new type of antibody in the blood of a dromedary. This led to the development of single-domain antibodies known as VHHs or Nanobodies® by former VIB researcher Serge Muyldermans. These tiny antibody fragments have resulted in the establishment of five VIB spin-off companies, including Ablynx, Biotalys, Confo Therapeutics, ExeVir Bio, and Animab. These companies are exploring the potential of VHHs as therapeutics for human and livestock diseases, crop protection, and drug discovery. Ongoing research at VIB continues to contribute to technological innovations in the VHH field.
Nanobodies, our legacy

Experimental micro-brewery of VIB and KU Leuven

In 2017, Professor Verstrepen received support from AB InBev and other partners to establish a state-of-the-art experimental brewery in Kasteelpark Arenberg, Leuven. The brewery serves as a platform for his team to investigate the behavior of yeast cells in large beer vessels. By bridging the gap between the laboratory and industry, the brewery and fermenters enable the study and testing of new yeast varieties, which can be applied in commercial beer production.
Experimental micro-brewery of VIB and KU Leuven

Safe test for mother and child

The group of Jurgen Del Favero (VIB-UAntwerp) developed an algorithm for PCR multiplexing, allowing highly reproducible simultaneous PCR amplification of hundreds of amplicons in a single reaction. This technology led to the creation of Multiplicom, a biotech start-up focused on developing innovative genetic analysis tools, including a non-invasive prenatal test (NIPT) for detecting birth defects early in pregnancy.
Safe test for mother and child

Blood test for liver diseases

VIB, in collaboration with Helena Biosciences, is set to commercialize a comprehensive blood test called Glyco Liver Profile for chronic liver diseases, a condition affecting up to 29 million people in the EU. This non-invasive test allows medical professionals to diagnose and monitor liver inflammation, fibrosis, and cirrhosis, providing an accurate and personalized alternative to invasive techniques.
Blood test for liver diseases

Agribiotech cluster in Ghent

Plant science is one of the cornerstones of VIB research. In VIB's Center for Plant Systems Biology at Ghent University, scientists study the cellular mechanisms that orchestrate plant growth and responses to the environment. Together with research partners from Flanders and beyond, these innovative insights are developed into agricultural applications and technologies that benefit society.
Agribiotech cluster in Ghent

Pagination

  • First page ‹‹
  • Previous page ‹
  • …
  • Page 19
  • Page 20
  • Current page 21
  • Page 22
  • Page 23
  • …
  • Next page ›
  • Last page ››

Footer

Keep me informed about VIB news and events
Home
  • Contact
  • Donate
  • Sitemap

VIB

Suzanne Tassierstraat 1
9052 Ghent
Belgium

BE 0456 343 923

+32 9 244 66 11info@vib.be

Follow us

facebook
instagram
bluesky
youtube
linkedin
vimeo
  • © VIB
  • Cookie policy
  • Disclaimer
  • Privacy
Administrator login Cookie preferences